3rd Nov 2016 13:58
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
1. | Details of the person discharging managerial responsibilities / person closely associated | ||||
a. | Name | Mr Christopher Tovey | |||
2. | Reason for the notification | ||||
a. | Position/status | Director/Chief Operating Officer | |||
b. | Initial notification /Amendment | Initial notification | |||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a. | Name | GW Pharmaceuticals PLC | |||
b. | LEI |
| |||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a. | Description of the Financial instrument, type of instrument Identification code |
Ordinary shares of 0.1p each ISIN: GB0030544687 Restricted American Depositary Shares: ISIN: US36197T1372 | |||
b. | Nature of the transaction | Conversion of 2,496 Ordinary shares into 208 Nasdaq listed Restricted ADRs (12 to 1 Conversion ratio) | |||
c. | Price(s) and volume(s) |
| |||
d. | Aggregated information ·Aggregated volume ·Price |
n/a | |||
e. | Date of the transaction | 2 November 2016 | |||
f. | Place of the transaction | New York | |||
Related Shares:
GWP.L